10/07/2026
The next decade of rare disease will be shaped by the decisions being made today.
At the 2026 NORD Breakthrough Summit, four CEOs at the forefront of rare disease innovation, patient care, and impact will come together for a forward-looking conversation on the opportunities, challenges, and decisions needed to shape what comes next—moderated by CNBC’s Becky Quick.
Featuring:
Alexander Hardy, President and CEO, BioMarin Pharmaceutical Inc.
Renee Gala, President and CEO, Jazz Pharmaceuticals
Tarek Rabah, President and CEO, Otsuka America Pharmaceutical, Inc.
Pamela Gavin, CEO, National Organization for Rare Disorders, Inc. (NORD)
Moderated by Becky Quick, co-anchor of CNBC's Squawk Box and host of CNBC Cures.
Join the conversation October 26–27 in Washington, D.C., or virtually. Register today: https://nordsummit.org